 |
|
|
| |
Nirmatrelvir/ritonavir or Molnupiravir for Treatment of Non-hospitalized Patients with COVID-19 at Risk of Disease Progression
|
| |
| |
ID Week 2923 Oct 14
Adeel A. Butt,1,2,3, Peng Yan,1 Obaid S, Shaikh,1,4
1VA Pittsburgh Healthcare System and Veterans Health Foundation, Pittsburgh, PA, USA; 2Weill Cornell Medical College, Doha, Qatar and New York, USA; 3Hamad Medical Corporation, Doha, Qatar; 4University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
|
| |
|
|
|
|
|
